Skip to main content
. 2020 Aug 25;12:7813–7826. doi: 10.2147/CMAR.S262567

Figure 1.

Figure 1

Comparison of survival curves between residual and non-residual group in patients with early-stage nasopharyngeal carcinoma (n=341) ((A) Overall survival; (B) Disease-free survival; (C) Relapse-free survival; (D) Distant metastasis-free survival).